Skip to content
10-Q

Quarterly Report

American CryoStem Corporation

0001019056-22-000229

← back to feed
Filed
Feb 22, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Feb 18, 2022 43.52M sh
Operating Cash Flow Q1 2022 · Dec 31, 2021 −$532.44K
Operating Cash Flow Q1 2022 · Dec 31, 2020 −$79.65K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $103.03K
Cash And Equivalents Q1 2022 · Sep 30, 2021 $8.24K
Cash And Equivalents restated Q1 2022 · Dec 31, 2020 −$2.56K
Cash And Equivalents restated Q1 2022 · Sep 30, 2020 $8.24K
Stockholders Equity Q1 2022 · Dec 31, 2021 −$1.43M
Stockholders Equity Q1 2022 · Sep 30, 2021 −$1.85M
Stockholders Equity Q1 2022 · Dec 31, 2020 −$359.73K
Stockholders Equity Q1 2022 · Sep 30, 2020 −$421.2K
Current Liabilities Q1 2022 · Dec 31, 2021 $1.37M
Current Liabilities Q1 2022 · Sep 30, 2021 $1.63M
Total Liabilities Q1 2022 · Dec 31, 2021 $2.57M
Total Liabilities Q1 2022 · Sep 30, 2021 $2.9M
Current Assets Q1 2022 · Dec 31, 2021 $288K
Current Assets Q1 2022 · Sep 30, 2021 $196.95K
Total Assets Q1 2022 · Dec 31, 2021 $1.14M
Total Assets Q1 2022 · Sep 30, 2021 $1.06M
Net Income Q1 2022 · Dec 31, 2021 −$380.76K
Net Income Q1 2022 · Dec 31, 2020 −$46.03K
Operating Income Q1 2022 · Dec 31, 2021 −$354.48K
Operating Income Q1 2022 · Dec 31, 2020 −$48.55K
Gross Profit Q1 2022 · Dec 31, 2021 $42.32K
Gross Profit Q1 2022 · Dec 31, 2020 $123.3K
Cost Of Revenue Q1 2022 · Dec 31, 2021 $18.86K
Cost Of Revenue Q1 2022 · Dec 31, 2020 $3.3K
Revenue Q1 2022 · Dec 31, 2021 $61.19K
Revenue Q1 2022 · Dec 31, 2020 $126.6K